Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹-357 Cr₹2,621 Cr₹1,270 Cr₹2,804 Cr₹3,033 Cr

What is the latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹-357 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹-357 Cr
Mar2023₹2,621 Cr
Mar2022₹1,270 Cr
Mar2021₹2,804 Cr
Mar2020₹3,033 Cr

How is Total Non-Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹-357 Cr
Negative
Mar2023 ₹2,621 Cr
106.48
Mar2022 ₹1,270 Cr
-54.72
Mar2021 ₹2,804 Cr
-7.56
Mar2020 ₹3,033 Cr -

Compare Total Non-Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,729.9 Cr 1.9% 4.8% 41.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,818.0 Cr -3.3% 3.4% 13.9% Stock Analytics
DIVIS LABORATORIES ₹164,628.0 Cr 4.1% 15.2% 60.2% Stock Analytics
CIPLA ₹120,775.0 Cr 0.6% 5.6% 11.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,758.0 Cr 1.9% 3.7% 28.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,791.0 Cr 6.2% 11.4% 2.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.9%

4.8%

41.7%

SENSEX

0.7%

9.6%

10.7%


You may also like the below Video Courses